WIPI2 Antikörper
(3 Referenzen)-
- Target Alle WIPI2 Antikörper anzeigen
- WIPI2 (WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2))
-
Reaktivität
- Human, Maus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser WIPI2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunofluorescence (IF)
- Kreuzreaktivität
- Maus
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- 2A2
- Isotyp
- IgG1
- Top Product
- Discover our top product WIPI2 Primärantikörper
-
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) antibody
WIPI2 Reaktivität: Human, Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 4-32), (N-Term) antibodyWIPI2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33312 unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (FITC)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal FITC
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (Biotin)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal Biotin
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (PE)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal PE
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 205-454) antibodyWIPI2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibodyWIPI2 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 187-436) antibodyWIPI2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 426-454), (C-Term) antibodyWIPI2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB24217 unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 427-445) antibodyWIPI2 Reaktivität: Human, Maus, Ratte, Meerschweinchen, Hamster WB, IHC, IHC (p), IP, IF Wirt: Maus Monoclonal 2A2 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1." in: Molecular cell, Vol. 55, Issue 2, pp. 238-52, (2014) (PubMed).
: "Imaging autophagy." in: Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.], Vol. 69, pp. 12.34.1-12.34.16, (2014) (PubMed).
: "Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation." in: Autophagy, Vol. 6, Issue 4, pp. 506-22, (2013) (PubMed).
-
: "WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1." in: Molecular cell, Vol. 55, Issue 2, pp. 238-52, (2014) (PubMed).
-
- Target
- WIPI2 (WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2))
- Andere Bezeichnung
- Wipi2 (WIPI2 Produkte)
- Gen-ID
- 26100, 74781
- UniProt
- Q80W47, Q9Y4P8
-
